{"id":"https://openalex.org/W3083172039","doi":"https://doi.org/10.1158/1538-7445.am2020-1023","title":"Abstract 1023: CD73 inhibition with a novel orally bioavailable small molecule blocks adenosine production and rescues T-cells activation","display_name":"Abstract 1023: CD73 inhibition with a novel orally bioavailable small molecule blocks adenosine production and rescues T-cells activation","alternate_titles":[],"publication_year":2020,"publication_date":"2020-08-15","ids":{"openalex":"https://openalex.org/W3083172039","doi":"https://doi.org/10.1158/1538-7445.am2020-1023","mag":"3083172039"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2020-1023","doi":"https://doi.org/10.1158/1538-7445.am2020-1023","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-1023","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3083172039"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012260072","display_name":"Tatiana Zavorotinskaya","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405264651","display_name":"ORIC Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/02hx4p162","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264651"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tatiana Zavorotinskaya","raw_affiliation_strings":["ORIC Pharmaceuticals, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ORIC Pharmaceuticals, CA","institution_ids":["https://openalex.org/I4405264651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039528755","display_name":"Brian R. Blank","orcid":"https://orcid.org/0009-0003-4763-9856","observed_orcids":["https://orcid.org/0009-0003-4763-9856"]},"institutions":[{"id":"https://openalex.org/I4405264651","display_name":"ORIC Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/02hx4p162","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264651"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Blank","raw_affiliation_strings":["ORIC Pharmaceuticals, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ORIC Pharmaceuticals, CA","institution_ids":["https://openalex.org/I4405264651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103920693","display_name":"Brenda C. Chan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405264651","display_name":"ORIC Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/02hx4p162","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264651"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brenda Chan","raw_affiliation_strings":["ORIC Pharmaceuticals, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ORIC Pharmaceuticals, CA","institution_ids":["https://openalex.org/I4405264651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103237462","display_name":"Chelsea Chen","orcid":"https://orcid.org/0000-0001-7776-4509","observed_orcids":["https://orcid.org/0000-0001-7776-4509"]},"institutions":[{"id":"https://openalex.org/I4405264651","display_name":"ORIC Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/02hx4p162","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264651"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chelsea Chen","raw_affiliation_strings":["ORIC Pharmaceuticals, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ORIC Pharmaceuticals, CA","institution_ids":["https://openalex.org/I4405264651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100610921","display_name":"Yuping Chen","orcid":"https://orcid.org/0009-0000-0101-9713","observed_orcids":["https://orcid.org/0009-0000-0101-9713","https://orcid.org/0009-0001-6850-8017"]},"institutions":[{"id":"https://openalex.org/I4405264651","display_name":"ORIC Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/02hx4p162","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264651"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yuping Chen","raw_affiliation_strings":["ORIC Pharmaceuticals, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ORIC Pharmaceuticals, CA","institution_ids":["https://openalex.org/I4405264651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101755327","display_name":"Xiaohui Du","orcid":"https://orcid.org/0000-0001-5444-9434","observed_orcids":["https://orcid.org/0000-0001-5444-9434"]},"institutions":[{"id":"https://openalex.org/I4405264651","display_name":"ORIC Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/02hx4p162","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264651"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaohui Du","raw_affiliation_strings":["ORIC Pharmaceuticals, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ORIC Pharmaceuticals, CA","institution_ids":["https://openalex.org/I4405264651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058421633","display_name":"Frank L. Duong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405264651","display_name":"ORIC Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/02hx4p162","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264651"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frank Duong","raw_affiliation_strings":["ORIC Pharmaceuticals, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ORIC Pharmaceuticals, CA","institution_ids":["https://openalex.org/I4405264651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103054591","display_name":"Lori S. Friedman","orcid":"https://orcid.org/0000-0001-9127-9892","observed_orcids":["https://orcid.org/0000-0001-9127-9892"]},"institutions":[{"id":"https://openalex.org/I4405264651","display_name":"ORIC Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/02hx4p162","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264651"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lori Friedman","raw_affiliation_strings":["ORIC Pharmaceuticals, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ORIC Pharmaceuticals, CA","institution_ids":["https://openalex.org/I4405264651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084676022","display_name":"Tom Huang","orcid":"https://orcid.org/0009-0005-8436-3099","observed_orcids":["https://orcid.org/0009-0005-8436-3099"]},"institutions":[{"id":"https://openalex.org/I4405264651","display_name":"ORIC Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/02hx4p162","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264651"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tom Huang","raw_affiliation_strings":["ORIC Pharmaceuticals, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ORIC Pharmaceuticals, CA","institution_ids":["https://openalex.org/I4405264651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040110214","display_name":"Melissa R. Junttila","orcid":"https://orcid.org/0000-0003-3538-1192","observed_orcids":["https://orcid.org/0000-0003-3538-1192"]},"institutions":[{"id":"https://openalex.org/I4405264651","display_name":"ORIC Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/02hx4p162","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264651"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa R. Junttila","raw_affiliation_strings":["ORIC Pharmaceuticals, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ORIC Pharmaceuticals, CA","institution_ids":["https://openalex.org/I4405264651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070534803","display_name":"Wayne Kong","orcid":"https://orcid.org/0009-0004-5288-9814","observed_orcids":["https://orcid.org/0009-0004-5288-9814"]},"institutions":[{"id":"https://openalex.org/I4405264651","display_name":"ORIC Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/02hx4p162","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264651"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wayne Kong","raw_affiliation_strings":["ORIC Pharmaceuticals, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ORIC Pharmaceuticals, CA","institution_ids":["https://openalex.org/I4405264651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041386973","display_name":"Todd C. Metzger","orcid":"https://orcid.org/0000-0002-5709-8876","observed_orcids":["https://orcid.org/0000-0002-5709-8876"]},"institutions":[{"id":"https://openalex.org/I4405264651","display_name":"ORIC Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/02hx4p162","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264651"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Todd C. Metzger","raw_affiliation_strings":["ORIC Pharmaceuticals, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ORIC Pharmaceuticals, CA","institution_ids":["https://openalex.org/I4405264651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052044439","display_name":"Jared T. Moore","orcid":"https://orcid.org/0000-0001-8197-7208","observed_orcids":["https://orcid.org/0000-0001-8197-7208"]},"institutions":[{"id":"https://openalex.org/I4405264651","display_name":"ORIC Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/02hx4p162","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264651"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jared T. Moore","raw_affiliation_strings":["ORIC Pharmaceuticals, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ORIC Pharmaceuticals, CA","institution_ids":["https://openalex.org/I4405264651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024655249","display_name":"Daqing Sun","orcid":"https://orcid.org/0000-0001-9578-8790","observed_orcids":["https://orcid.org/0000-0001-9578-8790"]},"institutions":[{"id":"https://openalex.org/I4405264651","display_name":"ORIC Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/02hx4p162","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264651"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daqing Sun","raw_affiliation_strings":["ORIC Pharmaceuticals, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ORIC Pharmaceuticals, CA","institution_ids":["https://openalex.org/I4405264651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103985374","display_name":"Jessica D. Sun","orcid":"https://orcid.org/0000-0002-9844-9767","observed_orcids":["https://orcid.org/0000-0002-9844-9767"]},"institutions":[{"id":"https://openalex.org/I4405264651","display_name":"ORIC Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/02hx4p162","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264651"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessica Sun","raw_affiliation_strings":["ORIC Pharmaceuticals, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ORIC Pharmaceuticals, CA","institution_ids":["https://openalex.org/I4405264651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040589084","display_name":"Dena Sutimantanapi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405264651","display_name":"ORIC Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/02hx4p162","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264651"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dena Sutimantanapi","raw_affiliation_strings":["ORIC Pharmaceuticals, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ORIC Pharmaceuticals, CA","institution_ids":["https://openalex.org/I4405264651"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034391681","display_name":"Natalie Yuen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405264651","display_name":"ORIC Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/02hx4p162","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264651"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Natalie Yuen","raw_affiliation_strings":["ORIC Pharmaceuticals, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ORIC Pharmaceuticals, CA","institution_ids":["https://openalex.org/I4405264651"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4405264651"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"80","issue":"16_Supplement","first_page":"1023","last_page":"1023"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13415","display_name":"Calcium signaling and nucleotide metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adenosine","display_name":"adenosine","score":0.8399999737739563},{"id":"https://openalex.org/keywords/ectonucleotidases","display_name":"ectonucleotidases","score":0.9259999990463257},{"id":"https://openalex.org/keywords/immunosuppressive-tumor-microenvironment","display_name":"immunosuppressive tumor microenvironment","score":0.9229999780654907},{"id":"https://openalex.org/keywords/cd8-t-cell-activation","display_name":"CD8+ T cell activation","score":0.9900000095367432},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.6579999923706055},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.4309999942779541},{"id":"https://openalex.org/keywords/adenosine-salvage-pathway","display_name":"adenosine salvage pathway","score":0.5009999871253967},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.5649999976158142},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.8939999938011169},{"id":"https://openalex.org/keywords/myeloid-cells","display_name":"myeloid cells","score":0.6919999718666077},{"id":"https://openalex.org/keywords/small-molecule-inhibitors","display_name":"small molecule inhibitors","score":0.375}],"concepts":[{"id":"https://openalex.org/C2776991684","wikidata":"https://www.wikidata.org/wiki/Q190012","display_name":"Adenosine","level":2,"score":0.8579832315444946},{"id":"https://openalex.org/C181912034","wikidata":"https://www.wikidata.org/wiki/Q1101143","display_name":"Dephosphorylation","level":4,"score":0.5829105377197266},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.5055840015411377},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4891567528247833},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.4716174900531769},{"id":"https://openalex.org/C28406088","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Extracellular","level":2,"score":0.46631795167922974},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.45032328367233276},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.4276413321495056},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41015467047691345},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.40919750928878784},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3892202377319336},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.37524646520614624},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.34770798683166504},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.343718558549881},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.20721957087516785},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.19112780690193176},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.11963462829589844},{"id":"https://openalex.org/C178666793","wikidata":"https://www.wikidata.org/wiki/Q422476","display_name":"Phosphatase","level":3,"score":0.07676646113395691}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2020-1023","doi":"https://doi.org/10.1158/1538-7445.am2020-1023","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-1023","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3000582265","https://openalex.org/W3081538624","https://openalex.org/W3176864666","https://openalex.org/W3083012635","https://openalex.org/W4247374436","https://openalex.org/W2742036288","https://openalex.org/W2547347394","https://openalex.org/W4415558620","https://openalex.org/W4362541336","https://openalex.org/W4282974164"],"abstract_inverted_index":{"Abstract":[0],"Adenosine":[1],"has":[2],"emerged":[3],"as":[4],"a":[5,243,312,417],"key":[6],"immunosuppressive":[7],"metabolite":[8],"within":[9],"the":[10,42,54,59,125,149,157,202,219,233,262,434,438],"tumor":[11,27],"microenvironment":[12],"(TME).":[13],"A":[14],"persistently":[15,317],"elevated":[16,357],"concentration":[17,220],"of":[18,26,36,45,61,67,96,103,127,141,152,159,189,195,204,211,221,235,252,264,280,299,315,340,345,370,433,437],"adenosine":[19,111,128,178,289,325,358,424],"in":[20,58,71,109,183,223,242,261,293,321],"TME":[21],"can":[22,256,334],"impair":[23],"immune":[24],"control":[25],"growth":[28],"by":[29,87,113,122,131],"diminishing":[30],"cytotoxic":[31,294],"T-cell":[32,164,213,259],"responses":[33],"and":[34,47,75,138,192,206,318,326,360,426,448],"function":[35,165,260],"natural":[37],"killer":[38],"cells":[39,310],"while":[40],"augmenting":[41],"suppressive":[43],"activity":[44,119,144],"myeloid":[46],"regulatory":[48],"T-cells.":[49,295],"The":[50],"ectonucleotidase,":[51],"CD73":[52,68,107,117,134,142,153,160,170,237,254,332,371,414],"mediates":[53],"final":[55],"dephosphorylation":[56],"step":[57],"conversion":[60],"extracellular":[62],"ATP":[63],"to":[64,83,168,176,229,239,274,286,323,372],"adenosine.":[65],"Overexpression":[66],"is":[69,174],"observed":[70],"many":[72],"solid":[73],"tumors":[74,224,355],"correlates":[76],"with":[77,416],"unfavorable":[78],"clinical":[79],"outcome.":[80],"We":[81,247,268,283],"aimed":[82,285],"overcome":[84],"adenosine-driven":[85],"immunosuppression":[86],"developing":[88],"an":[89,288,346,364],"orally":[90,365,419],"bioavailable,":[91],"best-in-class,":[92],"small":[93,367,421],"molecule":[94,368,422],"inhibitor":[95,108,118,369],"CD73.":[97],"Here,":[98],"we":[99,155,216,329],"show":[100],"superior":[101],"potency":[102],"our":[104,253,281],"selective":[105],"AMP-competitive":[106,236],"blocking":[110],"generation":[112,126,179],"multiple":[114],"cell":[115],"types.":[116],"was":[120,145],"assessed":[121],"directly":[123],"measuring":[124],"from":[129,180,227,305,363],"AMP":[130,181,205,222,245,266],"LC-MS/MS.":[132],"In":[133],"expressing":[135],"cells,":[136],"potent":[137],"complete":[139],"inhibition":[140,415],"ectonucleotidase":[143],"observed.":[146],"To":[147],"test":[148],"functional":[150],"consequence":[151],"inhibition,":[154],"interrogated":[156],"effects":[158,203],"inhibitors":[161,199,238,255,333],"on":[162,172],"CD8+":[163,212,303],"upon":[166],"exposure":[167],"AMP.":[169,327],"expressed":[171],"T-cells":[173,304,428],"sufficient":[175],"drive":[177],"resulting":[182],"severely":[184],"suppressed":[185],"proliferation,":[186],"diminished":[187],"production":[188,425],"inflammatory":[190],"cytokines":[191],"reduced":[193],"expression":[194,338],"activation":[196,429],"markers.":[197],"Our":[198],"successfully":[200],"counteracted":[201],"completely":[207,335],"rescued":[208],"all":[209],"aspects":[210],"activation.":[214],"Interestingly,":[215],"found":[217],"that":[218,249,331],"may":[225,350],"vary":[226],"micromolar":[228],"millimolar":[230,265],"levels,":[231],"underscoring":[232],"necessity":[234],"be":[240],"efficacious":[241],"high":[244],"environment.":[246],"demonstrated":[248,330],"nanomolar":[250],"concentrations":[251],"efficiently":[257],"rescue":[258],"presence":[263],"concentrations.":[267],"are":[269],"currently":[270],"conducting":[271],"biophysical":[272],"studies":[273],"better":[275],"understand":[276],"this":[277,341],"unique":[278,313],"property":[279],"inhibitors.":[282],"next":[284],"identify":[287,352],"responsive":[290],"gene":[291,337,348],"signature":[292,349],"RNA":[296],"sequencing":[297],"analysis":[298],"primary":[300],"anti-CD3/28/2":[301],"activated":[302],"human":[306],"peripheral":[307],"blood":[308],"mononuclear":[309],"revealed":[311],"set":[314],"genes":[316],"similarly":[319],"altered":[320],"response":[322],"both":[324],"Finally,":[328],"block":[336],"changes":[339],"AMP/adenosine-response":[342,347],"signature.":[343],"Discovery":[344],"help":[351],"patients":[353],"whose":[354],"harbor":[356],"signaling":[359],"would":[361],"benefit":[362],"bioavailable":[366,420],"reverse":[373],"immunosuppression.":[374],"Citation":[375],"Format:":[376],"Tatiana":[377],"Zavorotinskaya,":[378],"Brian":[379],"Blank,":[380],"Brenda":[381],"Chan,":[382],"Chelsea":[383],"Chen,":[384,386],"Yuping":[385],"Xiaohui":[387],"Du,":[388],"Frank":[389],"Duong,":[390],"Lori":[391],"Friedman,":[392],"Tom":[393],"Huang,":[394],"Melissa":[395],"R.":[396],"Junttila,":[397],"Wayne":[398],"Kong,":[399],"Todd":[400],"C.":[401],"Metzger,":[402],"Jared":[403],"T.":[404],"Moore,":[405],"Daqing":[406],"Sun,":[407,409],"Jessica":[408],"Dena":[410],"Sutimantanapi,":[411],"Natalie":[412],"Yuen.":[413],"novel":[418],"blocks":[423],"rescues":[427],"[abstract].":[430],"In:":[431],"Proceedings":[432],"Annual":[435],"Meeting":[436],"American":[439],"Association":[440],"for":[441],"Cancer":[442,454],"Research":[443],"2020;":[444],"2020":[445],"Apr":[446],"27-28":[447],"Jun":[449],"22-24.":[450],"Philadelphia":[451],"(PA):":[452],"AACR;":[453],"Res":[455],"2020;80(16":[456],"Suppl):Abstract":[457],"nr":[458],"1023.":[459]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3083172039","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2020-09-11T00:00:00"}
